The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review

Ovarian carcinosarcoma (OCS) is an uncommon and highly aggressive subtype of ovarian carcinoma characterized by the simultaneous occurrence of two malignant components: carcinomatous and sarcomatous. Located at the fimbrial region of the fallopian tube, serous tubal intraepithelial carcinoma (STIC) represents a form of precursor lesion for high-grade serous carcinoma (HGSC). In the current report, we present an intriguing case study of left OCS concomitant with ipsilateral STIC. Immunohistochemical (IHC) assessment showed a similar staining pattern of the carcinomatous OCS component and STIC. In conclusion, the development of OCS from STIC should be considered. Such a situation represents both a rare phenomenon and a challenge for preoperative diagnostic protocol. A careful application of selected IHC markers, p53 and Ki-67 in particular, may substantially help not only in the differential diagnosis but also in clinicopathological algorithms based on OCS molecular profiling into HGSC-like and non-HGSC-like variants.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-15
DOI
https://doi.org/10.3389/fonc.2026.1727634
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review

Dorota Lewkowicz, Andrzej Semczuk, Maciej Jóźwik, Paula Szlendak et al.
Frontiers in Oncology
Uterine Myomas and Treatments
article

The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review

Dorota Lewkowicz, Andrzej Semczuk, Maciej Jóźwik, Paula Szlendak, Marek Semczuk, Andrea Romano
article en

Abstract

Ovarian carcinosarcoma (OCS) is an uncommon and highly aggressive subtype of ovarian carcinoma characterized by the simultaneous occurrence of two malignant components: carcinomatous and sarcomatous. Located at the fimbrial region of the fallopian tube, serous tubal intraepithelial carcinoma (STIC) represents a form of precursor lesion for high-grade serous carcinoma (HGSC). In the current report, we present an intriguing case study of left OCS concomitant with ipsilateral STIC. Immunohistochemical (IHC) assessment showed a similar staining pattern of the carcinomatous OCS component and STIC. In conclusion, the development of OCS from STIC should be considered. Such a situation represents both a rare phenomenon and a challenge for preoperative diagnostic protocol. A careful application of selected IHC markers, p53 and Ki-67 in particular, may substantially help not only in the differential diagnosis but also in clinicopathological algorithms based on OCS molecular profiling into HGSC-like and non-HGSC-like variants.

Frontiers in OncologyVol. 16
Gynecologic Oncology Group (US), Medical University of Lublin (PL), Maastricht University Medical Centre (NL)
Good health and well-being
Openalex Percentile: Top 23%
Uterine Myomas and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review — Dorota Lewkowicz, Andrzej Semczuk, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS